Development of non-invasive diagnostic test based on fetal DNA isolated from maternal blood (NATERA-study)

Recruiting

• Conditions: 10083624; chromosomal aberriations; genetic defect

• Registration Number: NL-OMON37477
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Maternal blood samples:
> 18 years of age, informed consent given
diagnosis of abnormal or genetic disorder diagnosed by either amniocentesis or chorionic villus sampling
before (spontanious) abortion;Blood, buccal or saliva collection biological father:
>18 years, informed consent

Exclusion Criteria

Maternal blood samples:
After spontanious abortion or dilation and curettage

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The development and perfection of a noninvasive test in maternal blood<br /><br>detecting chromosomal aberrations.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>